BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that acquired Liberty Health Sciences Inc. (“Liberty” or the “Company”) (OTC: LHSIF) securities between June 28, 2018 and December 3, 2018, inclusive (the “Class Period”). Liberty investors have until March 8, 2019 to file a lead plaintiff motion.
In September 2018, Liberty sold its stake in Aphria Inc. (“Aphria”). On December 3, 2018, Quintessential Capital Management and Hindenburg Research issued a report entitled “Aphria: A Shell Game with a Cannabis Business on the Side,” claiming that Aphria was part of a scheme orchestrated by a network of insiders to divert funds away from shareholders and into their own pockets.
On this news, Liberty’s stock price fell $0.36 per share, or nearly 34%, over the next two trading days to close at $0.70 on December 4, 2018, thereby injuring investors.
The complaint filed in this class action alleges that defendants made false and/or misleading statements and/or failed to disclose that: (i) Liberty, in conjunction with Aphria, was involved in a scheme whereby numerous fraudulent acquisitions and transactions were made to provide undue benefits to both companies’ insiders; and (ii) as a result, Liberty’s public statements were materially false and misleading at all relevant times.
If you purchased shares of Liberty, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to email@example.com, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.